United Bank Biogen Inc. Transaction History

United Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 16, 2019	SELL	$216.71 - $338.96 $476,762 - $745,712	-2,200 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $612,700 - $776,050	2,200 New	2,200 $662,000
Q2 2018 Aug 20, 2018	SELL	$257.52 - $306.91 $341,729 - $407,269	-1,327 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$307.64 - $344.58 $11,075 - $12,404	36 Added 2.79%	1,327 $423,000
Q2 2017 Aug 23, 2017	BUY	N/A	1,291	1,291 $350,000

1,015

126M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of United Bank, based on Form 13F filings with the SEC.

Stay updated on United Bank with notifications on news.